19-42326368-G-T

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_001271938.2(MEGF8):​c.125G>T​(p.Gly42Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,436,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G42R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

MEGF8
NM_001271938.2 missense

Scores

10
8
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.91

Publications

0 publications found
Variant links:
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
  • MEGF8-related Carpenter syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Carpenter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.985

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEGF8NM_001271938.2 linkc.125G>T p.Gly42Val missense_variant Exon 1 of 42 ENST00000251268.11 NP_001258867.1 Q7Z7M0-1
MEGF8NM_001410.3 linkc.125G>T p.Gly42Val missense_variant Exon 1 of 41 NP_001401.2 Q7Z7M0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEGF8ENST00000251268.11 linkc.125G>T p.Gly42Val missense_variant Exon 1 of 42 5 NM_001271938.2 ENSP00000251268.5 Q7Z7M0-1
MEGF8ENST00000334370.8 linkc.125G>T p.Gly42Val missense_variant Exon 1 of 41 1 ENSP00000334219.4 Q7Z7M0-2
MEGF8ENST00000378073.5 linkc.-6961G>T 5_prime_UTR_variant Exon 1 of 41 5 ENSP00000367313.4 F5GZG7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000188
AC:
27
AN:
1436596
Hom.:
0
Cov.:
30
AF XY:
0.0000112
AC XY:
8
AN XY:
714770
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31466
American (AMR)
AF:
0.00
AC:
0
AN:
39458
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37322
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83026
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52688
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5686
European-Non Finnish (NFE)
AF:
0.0000227
AC:
25
AN:
1102260
Other (OTH)
AF:
0.0000337
AC:
2
AN:
59300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 13, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.125G>T (p.G42V) alteration is located in exon 1 (coding exon 1) of the MEGF8 gene. This alteration results from a G to T substitution at nucleotide position 125, causing the glycine (G) at amino acid position 42 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Uncertain
0.0
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.74
.;D
Eigen
Pathogenic
0.99
Eigen_PC
Pathogenic
0.93
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Pathogenic
0.60
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.51
D
MutationAssessor
Pathogenic
3.1
M;M
PhyloP100
8.9
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-6.5
D;D
REVEL
Pathogenic
0.73
Sift
Uncertain
0.0040
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.98
D;.
Vest4
0.60
MutPred
0.95
Loss of disorder (P = 0.1216);Loss of disorder (P = 0.1216);
MVP
0.71
MPC
1.3
ClinPred
0.99
D
GERP RS
5.6
Varity_R
0.87
gMVP
0.86
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2038983733; hg19: chr19-42830520; API